萬興科技(300624.SZ):現金收購深圳億圖51%股權交易完成
格隆匯7月26日丨萬興科技(300624.SZ)公佈,截至2022年7月26日,根據各方簽訂的《原協議》、《補充協議一》及《補充協議二》的約定,同時根據大華會計師事務所(特殊普通合夥)出具的《深圳市億圖軟件有限公司審計報吿》,深圳市億圖軟件有限公司(”深圳億圖“)2021年度業績淨利潤達到業績承諾,因此,第六期交易價款付款條件已全部滿足,公司於近日支付了第六期交易價款2550萬元。
截至2022年7月26日,公司現金收購深圳億圖51%股權的交易事項已全部完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.